Healthcare News and Analysis | Fox Business

'Varney & Co.' host Stuart Varney argues Kamala Harris' push for affordable health care and the Green New Deal will exacerbate our nation's debt crisis.

Those who need to carry epinephrine to treat potentially deadly allergic reactions now have an alternative option to an injection device.

A new report published by Fidelity shows that a 65-year-old retiring today can expect to spend $165,000 on health care – a 5% increase from last year.

The health care industry is dealing with increased attacks by cybercriminals. A cybersecurity expert said the rise is linked to the value of personal information that could be stolen.

Former President Trump tapped Senator JD Vance of Ohio as his running mate and vice presidential nominee for the 2024 GOP ticket, which has put a spotlight on Vance's policy views.

The U.S. government has awarded $176 million to Moderna for the development of its bird flu vaccine as the country faces a H5N1 virus outbreak in dairy cows.

New data published by GoodRx shows the cost of prescription drugs has surged 37% over the past decade, posing a "significant burden" to many Americans.

Rep. Tim Walberg, R-Mich, is introducing legislation to block the Department of Labor's move to rescind a Trump administration rule that expanded association health plans.

The Justice Department on Thursday announced the arrest of 193 people across the U.S. following a nationwide law enforcement crackdown on health care fraud.

The chief actuaries for Social Security and Medicare testified before the House Budget Committee about the two programs' looming insolvency roughly a decade from now.

Elizabeth Holmes' lawyers asked an appeals court to overturn her fraud conviction this week, but legal experts are torn over the Theranos founders' chances.

Some of London’s busiest hospitals canceled operations and other appointments Tuesday after a ransomware attack, the region's health service confirmed.

Pfizer expects its cancer drug Lorbrena to top $1 billion in annual sales by 2030 after most patients treated for a form of lung cancer had no disease progression after five years.

Telehealth company Ro has rolled out a new tool to track the supply of weight loss drugs like Ozempic and Wegovy across the U.S., as patients struggle with shortages.

EU regulators approved both a $1.52 billion joint hydrogen project funded by seven EU countries and a $1.1 billion joint health care project funded by six EU countries.

Health and wellness company Hims & Hers announced Monday that it is introducing injectable weight-loss drugs at a fraction of the cost of Ozempic and Wegovy.

ncG1vNJzZmivp6x7p7vXm6ysoZ6awLR6wqikaKCVlrm1tMKaqZ4%3D